Failed trial

Alzheimer; News from the web:

The companies developing aducanumab, Biogen and its partner Eisai, announced that they halted two late-stage trials of the experimental drug after an independent group’s analysis showed that the trials were unlikely to “meet their primary endpoint.”

The Cambridge, Massachusetts-based biotech giant joins a long list of companies in the last decade that have failed to find a treatment for Alzheimer’s.

Read all about it HERE

Get busy to stave off Alzheimer’s

Alzheimer; News from the web:

Physical activity can prevent dementia in the elderly. But activities that stimulate the brain, such as reading, going to concerts or weeding the garden, also lower the risk of Alzheimer’s disease regardless of how much physical activity the person does, a Swedish study says.

Read all about it HERE

What families can do

Alzheimer; News from the web:

In our link for today the second part about Alzheimer’s from the Alzheimer’s association, a great read.

Read all about it HERE

Alzheimer’s not limited to the elderly

Alzheimer; News from the web:

The majority of people affected by Alzheimer’s disease fit into a certain stereotype: senior citizens well over age 65, primarily women. For many people, this “senility” is not surprising. It’s even expected. But when the afflicted person is younger – in the prime of life – people are confused. Family members may be upset or angry. Doctors often are at a loss for a diagnosis.

Read all about it HERE